Form 4: Dyne Therapeutics CSO Oxana Beskrovnaya Sells Shares to Cover Tax Obligations

Oxana Beskrovnaya, Chief Scientific Officer of Dyne Therapeutics, sold shares to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On September 11, 2024, Oxana Beskrovnaya, the Chief Scientific Officer of Dyne Therapeutics, sold 2,161 shares of common stock.
• The sale was executed to satisfy tax withholding obligations associated with the vesting of restricted stock units (RSUs) granted on December 10, 2021, and December 9, 2022.
• The shares were sold at a weighted average price of $31.89, with individual transactions ranging from $31.59 to $32.15.
• Following the transaction, Beskrovnaya directly owns 142,714 shares, which includes 114,885 unvested RSUs.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction (sale of shares for tax obligations) and doesn't indicate any significant positive or negative sentiment.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives. This transaction is a routine part of executive compensation and tax management.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates